The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2023
DOI: 10.1186/s40246-023-00556-7
|View full text |Cite
|
Sign up to set email alerts
|

Dispersed DNA variants underlie hearing loss in South Florida’s minority population

LéShon Peart,
Joanna Gonzalez,
Dayna Morel Swols
et al.

Abstract: Background We analyzed the genetic causes of sensorineural hearing loss in racial and ethnic minorities of South Florida by reviewing demographic, phenotypic, and genetic data on 136 patients presenting to the Hereditary Hearing Loss Clinic at the University of Miami. In our retrospective chart review, of these patients, half self-identified as Hispanic, and the self-identified racial distribution was 115 (86%) White, 15 (11%) Black, and 6 (4%) Asian. Our analysis helps to reduce the gap in und… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…In addition, the prevalence of genetic impact and genetic factors associated with hearing impairment must be addressed to improve the unmet healthcare needs. The identification of new genetic variants associated with hearing loss in Latin America populations will pave the way for the development of effective screening tools and therapeutic strategies to either cure or slow down the progression of this condition [110,111].…”
Section: Current Situation In Latin Americamentioning
confidence: 99%
“…In addition, the prevalence of genetic impact and genetic factors associated with hearing impairment must be addressed to improve the unmet healthcare needs. The identification of new genetic variants associated with hearing loss in Latin America populations will pave the way for the development of effective screening tools and therapeutic strategies to either cure or slow down the progression of this condition [110,111].…”
Section: Current Situation In Latin Americamentioning
confidence: 99%
“…Therefore, MYH14 is included in gene panels for clinical testing (Abou Tayoun et al, 2016;Peart et al, 2023).…”
Section: Introductionmentioning
confidence: 99%